Moderna enters R&D collaboration for mRNA gene-editing therapies
By Syndicated ContentFeb 22, 2023 | 7:14 AM
(Reuters) – Moderna Inc said on Wednesday it had entered into a research and development collaboration with privately-owned Life Edit Therapeutics Inc to discover and develop mRNA gene-editing therapies.
For the health and safety of everyone, our offices are temporarily closed to the public. If you have won a prize from us we will be mailing it to you or will contact you with specific information needed to redeem your prize. Feel free to call us with questions during weekday business hours at (517) 279-1590.